Carcinogenesis, Vol. 21, No. 3, 427-433,
March 2000
© 2000 Oxford University Press
Carcinogenesis |
Hormonal carcinogenesis
Department of Preventive Medicine, USC/Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, MS44, PO Box 33800, Los Angeles, CA 90033-0800, USA
Hormone-related cancers, namely breast, endometrium, ovary, prostate, testis, thyroid and osteosarcoma, share a unique mechanism of carcinogenesis. Endogenous and exogenous hormones drive cell proliferation, and thus the opportunity for the accumulation of random genetic errors. The emergence of a malignant phenotype depends on a series of somatic mutations that occur during cell division, but the specific genes involved in progression of hormone-related cancers are currently unknown. In this review, the epidemiology of endometrial cancer and breast cancer are used to illustrate the paradigms of hormonal carcinogenesis. Then, new strategies for early detection and prevention of hormonal carcinogenesis are discussed. This includes developing polygenic models of cancer predisposition and the further development of safe and effective chemopreventives that block target sequence activity. We developed polygenic models for breast and prostate cancer after hypothesizing that functionally relevant sequence variants in genes involved in steroid hormone metabolism and transport would act together, and also interact with well-known hormonally related risk factors, to define a high-risk profile for cancer. A combination of genes each with minor variation in expressed activity could provide a degree of separation of risk that would be clinically useful as they could yield a large cumulative difference after several decades. The genes included in the breast cancer model are the 17ß-hydroxysteroid dehydrogenase 1 (HSD17B1) gene, the cytochrome P459c17
(CYP17) gene, the aromatase (CYP19) gene, and the estrogen receptor alpha (ER) gene. The prostate cancer model includes the androgen receptor gene (AR), steroid 5-reductase type II (SRD5A2), CYP17 and the 3ß hydroxysteroid dehydrogenase (HSD3B2) gene. We present data from our multi-ethnic cohort to support these models.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Z. Hammoud, B. Tan, S. Badve, and R. M Bigsby Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma Endocr. Relat. Cancer, June 1, 2008; 15(2): 475 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Henderson, L. Bernstein, B. Henderson, L. Kolonel, and M. C. Pike Predictors of the Timing of Natural Menopause in the Multiethnic Cohort Study Am. J. Epidemiol., June 1, 2008; 167(11): 1287 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Quick, P. G. Shields, J. Nie, M. E. Platek, S. E. McCann, A. D. Hutson, M. Trevisan, D. Vito, R. Modali, T. A. Lehman, et al. Effect Modification by Catalase Genotype Suggests a Role for Oxidative Stress in the Association of Hormone Replacement Therapy with Postmenopausal Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1082 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. W. Blank, P.-Y. Wong, R. Lakshmanaswamy, R. Guzman, and S. Nandi Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats PNAS, March 4, 2008; 105(9): 3527 - 3532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.D. Pereira, C. C. Lopes, A. J. F. Matos, D. Pinto, F. Gartner, C. Lopes, and R. Medeiros Estrogens Metabolism Associated with Polymorphisms: Influence of COMT G482a Genotype on Age at Onset of Canine Mammary Tumors Vet. Pathol., March 1, 2008; 45(2): 124 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Britt, A. Ashworth, and M. Smalley Pregnancy and the risk of breast cancer Endocr. Relat. Cancer, December 1, 2007; 14(4): 907 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-M. Lin, L.-R. Chen, E.-H. Lin, F.-C. Ke, H.-Y. Chen, M.-J. Tsai, and P.-W. Hsiao Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells Carcinogenesis, December 1, 2007; 28(12): 2521 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W. Setiawan, F. R. Schumacher, C. A. Haiman, D. O. Stram, D. Albanes, D. Altshuler, G. Berglund, J. Buring, E. E. Calle, F. Clavel-Chapelon, et al. CYP17 Genetic Variation and Risk of Breast and Prostate Cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3) Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2237 - 2246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shakhar, H. B. Valdimarsdottir, and D. H. Bovbjerg Heightened Risk of Breast Cancer Following Pregnancy: Could Lasting Systemic Immune Alterations Contribute? Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1082 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A Wood, J. E Fata, K. L M Watson, and R. Khokha Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus Reproduction, May 1, 2007; 133(5): 1035 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Henningson, U. Johansson, A. Borg, H. Olsson, and H. Jernstrom CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women Mol. Hum. Reprod., April 1, 2007; 13(4): 231 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. W. Setiawan, I. Cheng, D. O. Stram, E. Giorgi, M. C. Pike, D. Van Den Berg, L. Pooler, N. P. Burtt, L. Le Marchand, D. Altshuler, et al. A Systematic Assessment of Common Genetic Variation in CYP11A and Risk of Breast Cancer Cancer Res., December 15, 2006; 66(24): 12019 - 12025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Galeone, C. Pelucchi, F. Levi, E. Negri, S. Franceschi, R. Talamini, A. Giacosa, and C. La Vecchia Onion and garlic use and human cancer. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1027 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-M. HO, Y.-K. LEUNG, and I. CHUNG Estrogens and Antiestrogens as Etiological Factors and Therapeutics for Prostate Cancer Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 177 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Jasienska, M. Kapiszewska, P. T. Ellison, M. Kalemba-Drozdz, I. Nenko, I. Thune, and A. Ziomkiewicz CYP17 Genotypes Differ in Salivary 17-{beta} Estradiol Levels: A Study Based on Hormonal Profiles from Entire Menstrual Cycles. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2131 - 2135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W. Setiawan, C. A. Haiman, F. Z. Stanczyk, L. Le Marchand, and B. E. Henderson Racial/Ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1849 - 1855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kamangar, G. M. Dores, and W. F. Anderson Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World J. Clin. Oncol., May 10, 2006; 24(14): 2137 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Eliassen, S. A. Missmer, S. S. Tworoger, and S. E. Hankinson Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer: Does the Association Vary by a Woman's Predicted Breast Cancer Risk? J. Clin. Oncol., April 20, 2006; 24(12): 1823 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Vogel and E. Taioli Have We Found the Ultimate Risk Factor for Breast Cancer? J. Clin. Oncol., April 20, 2006; 24(12): 1791 - 1794. [Full Text] [PDF]
|
|
|
|
|
|
A. Kirschenbaum, X.-H. Liu, S. Yao, G. Narla, S. L. Friedman, J. A. Martignetti, and A. C. Levine Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones Carcinogenesis, February 1, 2006; 27(2): 216 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. BERSTEIN, E. V. TSYRLINA, D. A. VASILYEV, T. E. POROSHINA, and R. G. KOVALENKO The Phenomenon of the Switching of Estrogen Effects and Joker Function of Glucose: Similarities and Relation to Age-Associated Pathology and Approaches to Correction Ann. N.Y. Acad. Sci., December 1, 2005; 1057(1): 235 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E M Rosen, S Fan, and C Isaacs BRCA1 in hormonal carcinogenesis: basic and clinical research Endocr. Relat. Cancer, September 1, 2005; 12(3): 533 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Boers, M P A Zeegers, G M Swaen, I. Kant, and P A van den Brandt The influence of occupational exposure to pesticides, polycyclic aromatic hydrocarbons, diesel exhaust, metal dust, metal fumes, and mineral oil on prostate cancer: a prospective cohort study Occup. Environ. Med., August 1, 2005; 62(8): 531 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schairer, D. Hill, S. R. Sturgeon, T. Fears, C. Mies, R. G. Ziegler, R. N. Hoover, and M. E. Sherman Serum Concentrations of Estrogens, Sex Hormone Binding Globulin, and Androgens and Risk of Breast Hyperplasia in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1660 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. PROKAI-TATRAI and L. PROKAI Impact of Metabolism on the Safety of Estrogen Therapy Ann. N.Y. Acad. Sci., June 1, 2005; 1052(1): 243 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Johnson, J. Houck, and C. Chen Screening for Deleterious Nonsynonymous Single-Nucleotide Polymorphisms in Genes Involved in Steroid Hormone Metabolism and Response Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1326 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Onland-Moret, C. H. van Gils, M. Roest, D. E. Grobbee, and P. H.M. Peeters Cyp17, Urinary Sex Steroid Levels and Breast Cancer Risk in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 815 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Yue, J.-P. Wang, Y. Li, W. P. Bocchinfuso, K. S. Korach, P. D. Devanesan, E. Rogan, E. Cavalieri, and R. J. Santen Tamoxifen versus Aromatase Inhibitors for Breast Cancer Prevention Clin. Cancer Res., January 15, 2005; 11(2): 925s - 930s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Glud, S. K. Kjaer, B. L. Thomsen, C. Hogdall, L. Christensen, E. Hogdall, J. E. Bock, and J. Blaakaer Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer Arch Intern Med, November 8, 2004; 164(20): 2253 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V K Turan, R I Sanchez, J J Li, S A Li, K R Reuhl, P E Thomas, A H Conney, M A Gallo, F C Kauffman, and S Mesia-Vela The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17{beta}-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16{alpha}-hydroxyestradiol, and 4-hydroxyestrone J. Endocrinol., October 1, 2004; 183(1): 91 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Martin and K. T. Semple Environmental health impacts: occurrence, exposure and significance, Lancaster University, UK, 9-10 September 2003 Mutagenesis, September 1, 2004; 19(5): 423 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K Kjaer, L. Mellemkjaer, L. A Brinton, C. Johansen, G. Gridley, and J. H Olsen Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women Int. J. Epidemiol., June 1, 2004; 33(3): 596 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Borgono, I. P. Michael, and E. P. Diamandis Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer Mol. Cancer Res., May 1, 2004; 2(5): 257 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Scorilas, C. A. Borgono, N. Harbeck, J. Dorn, B. Schmalfeldt, M. Schmitt, and E. P. Diamandis Human Kallikrein 13 Protein in Ovarian Cancer Cytosols: A New Favorable Prognostic Marker J. Clin. Oncol., February 15, 2004; 22(4): 678 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W. Setiawan, S. E. Hankinson, G. A. Colditz, D. J. Hunter, and I. De Vivo HSD17B1 Gene Polymorphisms and Risk of Endometrial and Breast Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 213 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. Mason, D. Grove-Strawser, B. S. Rubin, R. A. Nowak, and J. J. Castellot Jr. Estrogen Induces CCN5 Expression in the Rat Uterus in Vivo Endocrinology, February 1, 2004; 145(2): 976 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Ramsey, K. E. Risinger, S. C. Jernigan, K. A. Mattingly, and C. M. Klinge Estrogen Receptor {beta} Isoforms Exhibit Differences in Ligand-Activated Transcriptional Activity in an Estrogen Response Element Sequence-Dependent Manner Endocrinology, January 1, 2004; 145(1): 149 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. G. SCHNEIDER Androgens and Antiandrogens Ann. N.Y. Acad. Sci., November 1, 2003; 997(1): 292 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Tilli, M. S. Frech, M. E. Steed, K. S. Hruska, M. D. Johnson, J. A. Flaws, and P. A. Furth Introduction of Estrogen Receptor-{alpha} into the tTA/TAg Conditional Mouse Model Precipitates the Development of Estrogen-Responsive Mammary Adenocarcinoma Am. J. Pathol., November 1, 2003; 163(5): 1713 - 1719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Haiman, D. O. Stram, M. C. Pike, L. N. Kolonel, N. P. Burtt, D. Altshuler, J. Hirschhorn, and B. E. Henderson A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort Hum. Mol. Genet., October 16, 2003; 12(20): 2679 - 2692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sasaki, M. Kaneuchi, N. Sakuragi, and R. Dahiya Multiple Promoters of Catechol-O-methyltransferase Gene Are Selectively Inactivated by CpG Hypermethylation in Endometrial Cancer Cancer Res., June 15, 2003; 63(12): 3101 - 3106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Hamilton and T. M. Mack Puberty and Genetic Susceptibility to Breast Cancer in a Case-Control Study in Twins N. Engl. J. Med., June 5, 2003; 348(23): 2313 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. F. Kadlubar, G. S. Berkowitz, R. R. Delongchamp, C. Wang, B. L. Green, G. Tang, J. Lamba, E. Schuetz, and M. S. Wolff The CYP3A4*1B Variant Is Related to the Onset of Puberty, A Known Risk Factor for the Development of Breast Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 327 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Bhat, G. Calaf, T. K. Hei, T. Loya, and J. V. Vadgama Critical role of oxidative stress in estrogen-induced carcinogenesis PNAS, April 1, 2003; 100(7): 3913 - 3918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. D. URNOV Chromatin as a Tool for the Study of Genome Function in Cancer Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 5 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Dai, X.-o. Shu, F. Jin, Y.-T. Gao, Z.-X. Ruan, and W. Zheng Consumption of Animal Foods, Cooking Methods, and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 801 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Yousef, A. Scorilas, L. G. Kyriakopoulou, L. Rendl, M. Diamandis, R. Ponzone, N. Biglia, M. Giai, R. Roagna, P. Sismondi, et al. Human Kallikrein Gene 5 (KLK5) Expression by Quantitative PCR: An Independent Indicator of Poor Prognosis in Breast Cancer Clin. Chem., August 1, 2002; 48(8): 1241 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Haydon, L. Zhou, T. Feng, B. Breyer, H. Cheng, W. Jiang, A. Ishikawa, T. Peabody, A. Montag, M. A. Simon, et al. Nuclear Receptor Agonists As Potential Differentiation Therapy Agents for Human Osteosarcoma Clin. Cancer Res., May 1, 2002; 8(5): 1288 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Syed, G. Ulinski, S. C. Mok, and S.-M. Ho Reproductive Hormone-Induced, STAT3-Mediated Interleukin 6 Action in Normal and Malignant Human Ovarian Surface Epithelial Cells J Natl Cancer Inst, April 17, 2002; 94(8): 617 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Cavalieri, P. Devanesan, M. C. Bosland, A. F. Badawi, and E. G. Rogan Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer Carcinogenesis, February 1, 2002; 23(2): 329 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. TOSETTI, N. FERRARI, S. DE FLORA, and A. ALBINI Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents FASEB J, January 1, 2002; 16(1): 2 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M.E Harvell, T. E. Strecker, B. Xie, K. L. Pennington, R. D. McComb, and J. D. Shull Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat Carcinogenesis, January 1, 2002; 23(1): 161 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Yang, G. Lu, F. Jin, Q. Dai, R. Best, X.-O. Shu, J.-R. Chen, X.-Y. Pan, M. Shrubsole, and W. Zheng Population-based, Case-control Study of Blood C-Peptide Level and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1207 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Onda, I. Nakamura, S. Suzuki, S. Takenoshita, C.-H. Brogren, S. Stampanoni, D. Li, and N. Rampino Microsatellite Instability in Thyroid Cancer: Hot Spots, Clinicopathological Implications, and Prognostic Significance Clin. Cancer Res., November 1, 2001; 7(11): 3444 - 3449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. AKHMEDKHANOV, A. ZELENIUCH-JACQUOTTE, and P. TONIOLO Role of Exogenous and Endogenous Hormones in Endometrial Cancer: Review of the Evidence and Research Perspectives Ann. N.Y. Acad. Sci., September 1, 2001; 943(1): 296 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Devanesan, R. J. Santen, W. P. Bocchinfuso, K. S. Korach, E. G. Rogan, and E. Cavalieri Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-{alpha} knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors Carcinogenesis, September 1, 2001; 22(9): 1573 - 1576. [Abstract] [Full Text] [PDF]
|
|
|
|